We previously identified that four of five putative N-linked glycosylation sites of human endothelial lipase (EL) are utilized and suggested that the substitution of asparagine-116 (Asn-116) with alanine (Ala) (N116A) increased the hydrolytic activity of EL. The current study demonstrates that mutagenesis of either Asn-116 to threonine (Thr) or Thr-118 to Ala also disrupted the glycosylation of EL and enhanced catalytic activity toward synthetic substrates by 3-fold versus wild-type EL. Furthermore, we assessed the hydrolysis of native lipoprotein lipids by EL-N116A. EL-N116A exhibited a 5-fold increase in LDL hydrolysis and a 1.8-fold increase in HDL 2 hydrolysis. Consistent with these observations, adenovirus-mediated expression of EL-N116A in mice significantly reduced the levels of both LDL and HDL cholesterol beyond the reductions observed by the expression of wild-type EL alone. Finally, we introduced Asn-116 of EL into the analogous positions within LPL and HL, resulting in N-linked glycosylation at this site. Glycosylation at this site suppressed the LPL hydrolysis of synthetic substrates, LDL, HDL 2 , and HDL 3 but had little effect on HL activity. These data suggest that N-linked glycosylation at Asn-116 reduces the ability of EL to hydrolyze lipids in LDL and HDL 2 .-Brown, R. J., G. C. Miller, N. Griffon, C. J. Long, and D. J. Rader. Glycosylation of endothelial lipase at asparagine-116 reduces activity and the hydrolysis of native lipoproteins in vitro and in vivo. J. Lipid Res. 2007Res. . 48: 1132Res. -1139.
Supplementary key words lipaseEndothelial lipase (EL) belongs to a superfamily of lipases (EC 3.1.1.3) that includes LPL and HL (1-6). These three lipases have both triglyceride (TG) lipase and phospholipase activity, but EL has relatively more phospholipase activity compared with LPL, which has predominantly TG lipase activity (7). Overexpression of EL in mice was shown to significantly reduce high density lipoprotein cholesterol (HDL-C) (1,8,9), whereas loss-of-function studies in mice result in significantly elevated plasma 10,11).In vitro and in vivo studies using chimeric proteins of LPL and HL have shown that the differences in substrate specificity between these two lipases are governed by a 22 amino acid loop, or "lid domain," within the N-terminal domain of the respective lipases that covers the catalytic site (12)(13)(14). The shorter 19 amino acid lid domain within EL partially contributes to its substrate specificity (15); other elements affecting substrate specificity remain to be elucidated.Human EL is translated as a 500 amino acid 57 kDa peptide that is processed into a mature 480 amino acid protein with an apparent molecular mass of 68 kDa after the loss of its signal peptide and the addition of N-linked glycosylation (1, 2). EL has five putative N-linked glycosylation sites [identified by the presence of asparagine-X-serine/threonine (Asn-Xaa-Ser/Thr) motifs]. We previously reported that four of the five sites, specifically are utilized (16). Abolishment of N-linke...